ARTICLE | Company News
Cellestis, Qiagen deal
July 18, 2011 7:00 AM UTC
Qiagen increased its offer to acquire diagnostics company Cellestis to A$3.80 per share in cash from A$3.55. The price values Cellestis at about A$359 million ($374 million) and is a 27% premium to Ce...